Velocity Clinical Research

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Migraine3 trials
• Obesity2 trials
• Macular degeneration1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 42 trials

Status

• Active, not recruiting3 trials
• Completed3 trials

Lead sponsor

• Pfizer3 trials
• Currax Pharmaceuticals1 trial
• Regor Pharmaceuticals Inc.1 trial
• Smilebiotek Zhuhai Limited1 trial

Running trials

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source

• Recruiting

  Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  NCT05156398· Phase 3· Pfizer· Source

• Recruiting

  Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  NCT04649242· Phase 3· Pfizer· Source

Closed trials

• Completed

  Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

  NCT06867718· Phase 2· Regor Pharmaceuticals Inc.· Source

• Completed

  QA102 Phase II Study in Subjects With Dry AMD

  NCT05536752· Phase 2· Smilebiotek Zhuhai Limited· Source

• Completed

  Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

  NCT05207865· Phase 4· Pfizer· Source